{"DataElement":{"publicId":"3121628","version":"4","preferredName":"Molecular Analysis Abnormal Testing Result","preferredDefinition":"Term to describe an abnormal result of molecular analysis.","longName":"3121577v1.00:3121599v1.30","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3121577","version":"1","preferredName":"Molecular Analysis Abnormal Result","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA)._Deviating from the norm._Outcome; a phenomenon that follows and is caused by some previous phenomenon._","longName":"2626369v1.0:2207618v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2626369","version":"1","preferredName":"Molecular Analysis","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).","longName":"C19770","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E013094-1F05-11C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207618","version":"1","preferredName":"Abnormal Result","preferredDefinition":"Deviating from the norm.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C25401:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2A42-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-EA3B-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3121599","version":"1.3","preferredName":"Molecular Analysis Abnormality Testing Result","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA)._A condition that differs from the usual physical or mental state._A procedure for critical evaluation._Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"3121599v1.30","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HPV positive","valueDescription":"Human Papillomavirus Positive Finding","ValueMeaning":{"publicId":"4514743","version":"1","preferredName":"Human Papillomavirus Positive Finding","longName":"4514743","preferredDefinition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C77-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81EA-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"HER2/ERBB2 Status by IHC","valueDescription":"Status Immunohistochemistry Staining Method ERBB2 Protein","ValueMeaning":{"publicId":"4514742","version":"1","preferredName":"Status Immunohistochemistry Staining Method ERBB2 Protein","longName":"4514742","preferredDefinition":"A condition or state at a particular time.: Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.: The ERBB2 gene encodes two forms of ERBB2 protein.  One is a transmembrane protein that forms a heterodimer to act as the heregulin/neuregulin receptor. The other is a secreted form that consists only of the extracellular domain. It is capable of disrupting ERBB2 dimers thereby inhibiting growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene Product","conceptCode":"C45842","definition":"A protein encoded by the ERBB2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C51-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81EB-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"HER2/ERBB2 Status by FISH","valueDescription":"Status Fluorescence in Situ Hybridization ERBB2 Gene","ValueMeaning":{"publicId":"4514740","version":"1","preferredName":"Status Fluorescence in Situ Hybridization ERBB2 Gene","longName":"4514740","preferredDefinition":"A condition or state at a particular time.: A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.: This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C29-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81EC-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"HER2/Centromere 17 Ratio","valueDescription":"Centromere Chromosome 17 Ratio ERBB2 Gene","ValueMeaning":{"publicId":"4514739","version":"1","preferredName":"Centromere Chromosome 17 Ratio ERBB2 Gene","longName":"4514739","preferredDefinition":"The nonstaining primary constriction of a chromosome which is the point of attachment of the spindle fiber; provides the mechanism of chromosome movement during cell division; the centromere divides the chromosome into two arms, and its position is constant for a specific chromosome: near one end (acrocentric), near the center (metacentric), or between (submetacentric).: The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: Quotient of quantities of the same kind for different components within the same system.: This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Centromere","conceptCode":"C13198","definition":"The nonstaining primary constriction of a chromosome which is the point of attachment of the spindle fiber; provides the mechanism of chromosome movement during cell division; the centromere divides the chromosome into two arms, and its position is constant for a specific chromosome: near one end (acrocentric), near the center (metacentric), or between (submetacentric).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Human Chromosome 17","conceptCode":"C13212","definition":"The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C02-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81ED-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"HER2 mutation","valueDescription":"ERBB2 Gene Mutation","ValueMeaning":{"publicId":"4514738","version":"1","preferredName":"ERBB2 Gene Mutation","longName":"4514738","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the ERBB2 gene on chromosome 17q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene Mutation","conceptCode":"C96866","definition":"A molecular genetic abnormality indicating the presence of a mutation in the ERBB2 gene on chromosome 17q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7BDA-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81EE-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR exon 20 insertion","valueDescription":"Insertion Mutation Exon Twenty EGFR Gene","ValueMeaning":{"publicId":"4514724","version":"1","preferredName":"Insertion Mutation Exon Twenty EGFR Gene","longName":"4514724","preferredDefinition":"Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA.: The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insertion Mutation","conceptCode":"C19295","definition":"Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twenty","conceptCode":"C105799","definition":"A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7AB6-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81EF-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR exon 19 deletion","valueDescription":"EGFR Exon 19 Deletion","ValueMeaning":{"publicId":"4514723","version":"1","preferredName":"EGFR Exon 19 Deletion","longName":"4514723","preferredDefinition":"Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.: The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A natural number greater than eighteen and less than twenty and the quantity that it denotes.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deletion Mutation","conceptCode":"C19296","definition":"Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Nineteen","conceptCode":"C105801","definition":"A natural number greater than eighteen and less than twenty and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A8E-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F0-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - FAP mutations","valueDescription":"Germline Genotype Testing FAP Gene Mutation","ValueMeaning":{"publicId":"4535017","version":"1","preferredName":"Germline Genotype Testing FAP Gene Mutation","longName":"4535017","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the FAP gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FAP Gene Mutation","conceptCode":"C118386","definition":"A change in the nucleotide sequence of the FAP gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9797-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F1-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - DNA mismatch Repair","valueDescription":"Mismatch Repair","ValueMeaning":{"publicId":"4514736","version":"1","preferredName":"Mismatch Repair","longName":"4514736","preferredDefinition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair","conceptCode":"C20639","definition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B9E-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F2-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FGFR translocation","valueDescription":"FGFR Gene Translocation","ValueMeaning":{"publicId":"4535016","version":"1","preferredName":"FGFR Gene Translocation","longName":"4535016","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of an FGFR family gene to a new chromosomal location.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGFR Gene Translocation","conceptCode":"C118377","definition":"A cytogenetic abnormality that refers to the translocation of an FGFR family gene to a new chromosomal location.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9771-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"COLBERTM","dateModified":"2019-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F3-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FGFR amplification","valueDescription":"FGFR Gene Amplification","ValueMeaning":{"publicId":"4535015","version":"1","preferredName":"FGFR Gene Amplification","longName":"4535015","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGFR family gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGFR Gene Amplification","conceptCode":"C118378","definition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGFR family gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-974C-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"COLBERTM","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F4-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FGF amplification","valueDescription":"FGF Gene Amplification","ValueMeaning":{"publicId":"4535014","version":"1","preferredName":"FGF Gene Amplification","longName":"4535014","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGF family gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGF Gene Amplification","conceptCode":"C118376","definition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGF family gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9727-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F5-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"ER positive","valueDescription":"Estrogen Receptor Positive","ValueMeaning":{"publicId":"4264820","version":"1","preferredName":"Estrogen Receptor Positive","longName":"4264820","preferredDefinition":"Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow, and may stop growing or die when treated with substances that block the binding and actions of estrogen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Positive","conceptCode":"C15492","definition":"An indication that estrogen receptor alpha expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FD23-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F6-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 5","valueDescription":"EML4/ALK Fusion Gene Variant 5b EML4/ALK Fusion Gene Variant 5a","ValueMeaning":{"publicId":"4514735","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 5b EML4/ALK Fusion Gene Variant 5a","longName":"4514735","preferredDefinition":"A fusion gene (~2.1 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with approximately 115 nucleotides of intron 19 and exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.: A fusion gene (~2.0 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 5b","conceptCode":"C99732","definition":"A fusion gene (~2.1 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with approximately 115 nucleotides of intron 19 and exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EML4/ALK Fusion Gene Variant 5a","conceptCode":"C99731","definition":"A fusion gene (~2.0 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B79-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F7-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 4","valueDescription":"EML4/ALK Fusion Gene Variant 4","ValueMeaning":{"publicId":"4408814","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 4","longName":"4408814","preferredDefinition":"A fusion gene (~3.4 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 14 of the EML4 gene and an 11 nucleotide linker sequence with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 4","conceptCode":"C99730","definition":"A fusion gene (~3.4 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 14 of the EML4 gene and an 11 nucleotide linker sequence with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D02-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F8-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 3","valueDescription":"EML4/ALK Fusion Gene Variant 3b EML4/ALK Fusion Gene Variant 3a","ValueMeaning":{"publicId":"4514732","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 3b EML4/ALK Fusion Gene Variant 3a","longName":"4514732","preferredDefinition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6b of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.: A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6a of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 3b","conceptCode":"C99729","definition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6b of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EML4/ALK Fusion Gene Variant 3a","conceptCode":"C99727","definition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6a of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B51-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81F9-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 2","valueDescription":"EML4/ALK Fusion Gene Variant 2","ValueMeaning":{"publicId":"4408816","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 2","longName":"4408816","preferredDefinition":"A fusion gene (~4.7 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 20 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 2","conceptCode":"C99726","definition":"A fusion gene (~4.7 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 20 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D28-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FA-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation","valueDescription":"EML4/ALK Fusion Gene","ValueMeaning":{"publicId":"4408812","version":"1","preferredName":"EML4/ALK Fusion Gene","longName":"4408812","preferredDefinition":"A fusion gene that results from a chromosomal inversion inv(2)(p21p23) which fuses the 5' portion of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene","conceptCode":"C99724","definition":"A fusion gene that results from a chromosomal inversion inv(2)(p21p23) which fuses the 5' portion of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2CDC-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FB-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFRviii mutation","valueDescription":"EGFRvIII Antibody","ValueMeaning":{"publicId":"4277000","version":"1","preferredName":"EGFRvIII Antibody","longName":"4277000","preferredDefinition":"An antibody directed against the epidermal growth factor receptor class III variant (EGFRvIII).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFRvIII Antibody","conceptCode":"C114794","definition":"An antibody directed against the epidermal growth factor receptor class III variant (EGFRvIII).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A2ED0B-933B-456B-E040-BB89AD436E25","latestVersionIndicator":"Yes","beginDate":"2014-04-22","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-04-22","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FC-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR T790M mutation","valueDescription":"EGFR NP_005219.2:p.T790M","ValueMeaning":{"publicId":"4408819","version":"1","preferredName":"EGFR NP_005219.2:p.T790M","longName":"4408819","preferredDefinition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.T790M","conceptCode":"C98503","definition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D9D-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FD-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Beta-HCG elevated","valueDescription":"Elevated Choriogonadotropin Subunit Beta","ValueMeaning":{"publicId":"4408823","version":"1","preferredName":"Elevated Choriogonadotropin Subunit Beta","longName":"4408823","preferredDefinition":"Raised or increased above normal levels or limits.: The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or Trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (Scan J Clin Lab Invest Suppl 1993;216:97-104)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Choriogonadotropin Subunit Beta 3","conceptCode":"C17479","definition":"Choriogonadotropin subunit beta 3 (165 aa, ~18 kDa) is encoded by the human CGB3, CGB5, and CGB8 genes. This protein is involved in the regulation of steroid synthesis during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E24-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FE-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BCR-ABL translocation","valueDescription":"BCR/ABL1 Fusion Gene","ValueMeaning":{"publicId":"3935833","version":"1","preferredName":"BCR/ABL1 Fusion Gene","longName":"3935833","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-298C-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-81FF-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Androgen receptor expression","valueDescription":"Androgen Receptor Positive","ValueMeaning":{"publicId":"4408825","version":"1","preferredName":"Androgen Receptor Positive","longName":"4408825","preferredDefinition":"Describes cells that have a protein that binds to androgens (male hormones). Cancer cells that are AR+ may need androgens to grow. These cells may stop growing or die when they are treated with substances that block the binding and actions of androgen hormones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Androgen Receptor Positive","conceptCode":"C94297","definition":"An indication that expression of androgen receptor has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E5F-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8200-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"AFP elevated","valueDescription":"Elevated Alpha-Fetoprotein","ValueMeaning":{"publicId":"4408826","version":"1","preferredName":"Elevated Alpha-Fetoprotein","longName":"4408826","preferredDefinition":"Raised or increased above normal levels or limits.: Alpha-fetoprotein is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. (from LocusLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alpha-Fetoprotein","conceptCode":"C16278","definition":"Alpha-fetoprotein (609 aa, ~69 kDa) is encoded by the human AFP gene. This protein plays a role in the binding to copper, nickel, bilirubin and fatty acids in the fetal circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E85-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8201-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Unknown elevated","valueDescription":"Unknown Adrenal Androgen Excess","ValueMeaning":{"publicId":"4514715","version":"1","preferredName":"Unknown Adrenal Androgen Excess","longName":"4514715","preferredDefinition":"Not known, not observed, not recorded, or refused.: Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-79C5-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8202-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - None elevated","valueDescription":"None Adrenal Androgen Excess","ValueMeaning":{"publicId":"4514714","version":"1","preferredName":"None Adrenal Androgen Excess","longName":"4514714","preferredDefinition":"No person or thing, nobody, not any.: Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-799F-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8203-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Mineralocorticoids elevated","valueDescription":"Elevated Mineralocorticoid","ValueMeaning":{"publicId":"4408788","version":"1","preferredName":"Elevated Mineralocorticoid","longName":"4408788","preferredDefinition":"Raised or increased above normal levels or limits.: A class of corticosteroid hormones that maintains fluid and electrolyte balance. The main mineralocorticoid is Aldosterone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mineralocorticoid","conceptCode":"C2324","definition":"A class of corticosteroid hormones that maintains fluid and electrolyte balance. The main mineralocorticoid is Aldosterone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ED43-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8204-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Cortisol elevated","valueDescription":"Elevated Cortisol","ValueMeaning":{"publicId":"4408774","version":"1","preferredName":"Elevated Cortisol","longName":"4408774","preferredDefinition":"Raised or increased above normal levels or limits.: A hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps the body use glucose (a sugar), protein, and fats. Cortisol made in the laboratory is called hydrocortisone. It is used to treat many conditions, including inflammation, allergies, and some cancers. Cortisol is a type of glucocorticoid hormone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cortisol","conceptCode":"C2290","definition":"A hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps the body use glucose (a sugar), protein, and fats. Cortisol made in the laboratory is called hydrocortisone. It is used to treat many conditions, including inflammation, allergies, and some cancers. Cortisol is a type of glucocorticoid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EBA0-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8205-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Androgen elevated","valueDescription":"Adrenal Androgen Excess","ValueMeaning":{"publicId":"4408776","version":"1","preferredName":"Adrenal Androgen Excess","longName":"4408776","preferredDefinition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EBC6-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8206-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"17p deletion","valueDescription":"Loss of Chromosome 17p","ValueMeaning":{"publicId":"4534971","version":"1","preferredName":"Loss of Chromosome 17p","longName":"4534971","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the short arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 17p","conceptCode":"C36499","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05633FB3-FD67-B268-E050-BB89AD431E51","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8207-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR resistance mutation","valueDescription":"EGFR-TKI Resistant Mutation","ValueMeaning":{"publicId":"4514729","version":"1","preferredName":"EGFR-TKI Resistant Mutation","longName":"4514729","preferredDefinition":"A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations of the EGFR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR-TKI Resistant Mutation","conceptCode":"C96862","definition":"A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B29-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8208-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR overexpression","valueDescription":"EGFR Protein Overexpression","ValueMeaning":{"publicId":"4535013","version":"1","preferredName":"EGFR Protein Overexpression","longName":"4535013","preferredDefinition":"A molecular genetic abnormality indicating the presence of an abnormally high level of EGFR protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Protein Overexpression","conceptCode":"C39716","definition":"A molecular genetic abnormality indicating the presence of an abnormally high level of EGFR protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9702-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8209-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR other mutations","valueDescription":"EGFR Other Mutation(s)","ValueMeaning":{"publicId":"4514725","version":"1","preferredName":"EGFR Other Mutation(s)","longName":"4514725","preferredDefinition":"change occurring in one gene.: Different than the one(s) previously specified or mentioned.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7ADD-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820A-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR L861Q mutation","valueDescription":"EGFR NP_005219.2:p.L861Q","ValueMeaning":{"publicId":"3799870","version":"1","preferredName":"EGFR NP_005219.2:p.L861Q","longName":"3799870","preferredDefinition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L861Q","conceptCode":"C98497","definition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0285152-B138-3145-E040-BB89AD436AA6","latestVersionIndicator":"Yes","beginDate":"2013-06-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-06-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820B-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR L858R mutation","valueDescription":"EGFR NP_005219.2:p.L858R","ValueMeaning":{"publicId":"4408779","version":"1","preferredName":"EGFR NP_005219.2:p.L858R","longName":"4408779","preferredDefinition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L858R","conceptCode":"C98515","definition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EC26-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820C-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR G719X mutation","valueDescription":"EGFR NP_005219.2:p.G719X","ValueMeaning":{"publicId":"3800322","version":"1","preferredName":"EGFR NP_005219.2:p.G719X","longName":"3800322","preferredDefinition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G719X","conceptCode":"C107154","definition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0391E43-574B-5A36-E040-BB89AD433003","latestVersionIndicator":"Yes","beginDate":"2013-06-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-06-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820D-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Other Not Tested","valueDescription":"Other Not Tested","ValueMeaning":{"publicId":"3121600","version":"1","preferredName":"Other Not Tested","longName":"3121600","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of an enzyme or other protein. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gene","conceptCode":"C16612","definition":"A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2A3F-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820E-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Other Positive","valueDescription":"Other Positive","ValueMeaning":{"publicId":"3121601","version":"1","preferredName":"Other Positive","longName":"3121601","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of an enzyme or other protein. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gene","conceptCode":"C16612","definition":"A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2A62-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-820F-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Other Negative","valueDescription":"Other Negative","ValueMeaning":{"publicId":"3121602","version":"1","preferredName":"Other Negative","longName":"3121602","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of an enzyme or other protein. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gene","conceptCode":"C16612","definition":"A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2A85-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8210-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NPMc Not Tested","valueDescription":"NPMc Not Tested","ValueMeaning":{"publicId":"3121603","version":"1","preferredName":"NPMc Not Tested","longName":"3121603","preferredDefinition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytoplasmic Nucleophosmin Expression","conceptCode":"C117284","definition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2AA8-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8211-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NPMc Positive","valueDescription":"NPMc Positive","ValueMeaning":{"publicId":"3121604","version":"1","preferredName":"NPMc Positive","longName":"3121604","preferredDefinition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytoplasmic Nucleophosmin Expression","conceptCode":"C117284","definition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2ACB-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8212-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NPMc Negative","valueDescription":"NPMc Negative","ValueMeaning":{"publicId":"3121605","version":"1","preferredName":"NPMc Negative","longName":"3121605","preferredDefinition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytoplasmic Nucleophosmin Expression","conceptCode":"C117284","definition":"A variant form of nucleophosmin with cytoplasmic expression. These variants have either a 4-base or 9-base insertion in exon 12 of the NPM1 gene. Acute myelogenous leukemia with normal cytogenetics and cytoplasmic nucleophosmin (NPMc+ AML) constitutes about one third of the cases of primary AML in adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2AEE-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8213-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Activating RAS Not Tested","valueDescription":"Activating RAS Not Tested","ValueMeaning":{"publicId":"3121606","version":"1","preferredName":"Activating RAS Not Tested","longName":"3121606","preferredDefinition":"To cause something to start; stimulation of activity.: A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activation","conceptCode":"C64382","definition":"To cause something to start or to stimulate activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"RAS Family Gene","conceptCode":"C25784","definition":"A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2B11-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8214-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Activating RAS Negative","valueDescription":"Activating RAS Negative","ValueMeaning":{"publicId":"3121607","version":"1","preferredName":"Activating RAS Negative","longName":"3121607","preferredDefinition":"To cause something to start; stimulation of activity.: A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activation","conceptCode":"C64382","definition":"To cause something to start or to stimulate activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"RAS Family Gene","conceptCode":"C25784","definition":"A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2B34-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8215-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Activating RAS Positive","valueDescription":"Activating RAS Positive","ValueMeaning":{"publicId":"3121608","version":"1","preferredName":"Activating RAS Positive","longName":"3121608","preferredDefinition":"To cause something to start; stimulation of activity.: A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activation","conceptCode":"C64382","definition":"To cause something to start or to stimulate activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"RAS Family Gene","conceptCode":"C25784","definition":"A family of genes that encode structurally similar small GTPases involved in a variety of signal transduction pathways. Mutation of genes in this family is associated with cancer.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2B57-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8216-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH1 R132 Not Tested","valueDescription":"IDH1 R132 Not Tested","ValueMeaning":{"publicId":"3121615","version":"1","preferredName":"IDH1 R132 Not Tested","longName":"3121615","preferredDefinition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 NP_005887.2:p.R132X","conceptCode":"C117280","definition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2C4C-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8217-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH1 R132 Positive","valueDescription":"IDH1 R132 Positive","ValueMeaning":{"publicId":"3121616","version":"1","preferredName":"IDH1 R132 Positive","longName":"3121616","preferredDefinition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 NP_005887.2:p.R132X","conceptCode":"C117280","definition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2C6F-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8218-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH1 R132 Negative","valueDescription":"IDH1 R132 Negative","ValueMeaning":{"publicId":"3121617","version":"1","preferredName":"IDH1 R132 Negative","longName":"3121617","preferredDefinition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 NP_005887.2:p.R132X","conceptCode":"C117280","definition":"A change in the amino acid residue at position 132 in the isocitrate dehydrogenase [NADP] cytoplasmic protein where arginine has been replaced by another amino acid. Mutations at this position occur frequently in high-grade gliomas but not in other solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2C92-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8219-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FLT3 Mutation Not Tested","valueDescription":"FLT3 Mutation Not Tested","ValueMeaning":{"publicId":"3121618","version":"1","preferredName":"FLT3 Mutation Not Tested","longName":"3121618","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.: A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 gene","conceptCode":"C1333568","definition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2CB5-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821A-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FLT3 Mutation Positive","valueDescription":"FLT3 Mutation Positive","ValueMeaning":{"publicId":"3121619","version":"1","preferredName":"FLT3 Mutation Positive","longName":"3121619","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.: A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 gene","conceptCode":"C1333568","definition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2CD8-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821B-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FLT3 Mutation Negative","valueDescription":"FLT3 Mutation Negative","ValueMeaning":{"publicId":"3121620","version":"1","preferredName":"FLT3 Mutation Negative","longName":"3121620","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.: A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Gene","conceptCode":"C24399","definition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2CFB-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821C-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PML-RAR Not Tested","valueDescription":"PML-RAR Not Tested","ValueMeaning":{"publicId":"3121621","version":"1","preferredName":"PML-RAR Not Tested","longName":"3121621","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PML/RARA Fusion Gene","conceptCode":"C99186","definition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2D1E-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821D-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PML-RAR Positive","valueDescription":"PML-RAR Positive","ValueMeaning":{"publicId":"3121622","version":"1","preferredName":"PML-RAR Positive","longName":"3121622","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PML/RARA Fusion Gene","conceptCode":"C99186","definition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2D41-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821E-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PML-RAR Negative","valueDescription":"PML-RAR Negative","ValueMeaning":{"publicId":"3121623","version":"1","preferredName":"PML-RAR Negative","longName":"3121623","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PML/RARA Fusion Gene","conceptCode":"C99186","definition":"A fusion gene that results from a chromosomal translocation t(15;17)(q22;q21) which fuses the first 3 exons of the PML gene with the last 7 exons of the RARA gene. This fusion is associated with acute promyelocytic leukemia. Three transcript variants are possible based on the three breakpoint clusters in the PML gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2D64-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-821F-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BCR-ABL Not Tested","valueDescription":"BCR-ABL Not Tested","ValueMeaning":{"publicId":"3121624","version":"1","preferredName":"BCR-ABL Not Tested","longName":"3121624","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2D87-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8220-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BCR-ABL Positive","valueDescription":"BCR-ABL Positive","ValueMeaning":{"publicId":"3121625","version":"1","preferredName":"BCR-ABL Positive","longName":"3121625","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2DAA-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8221-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BCR-ABL Negative","valueDescription":"BCR-ABL Negative","ValueMeaning":{"publicId":"3121626","version":"1","preferredName":"BCR-ABL Negative","longName":"3121626","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2DCD-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8222-03C7-E063-731AD00A2106","beginDate":"2010-07-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"JAK2 V617 Not Tested","valueDescription":"JAK2 V617 Not Tested","ValueMeaning":{"publicId":"3144417","version":"1","preferredName":"JAK2 V617 Not Tested","longName":"3144417","preferredDefinition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"JAK2 NP_004963.1:p.V617X","conceptCode":"C117283","definition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"917B00C1-34BF-B5C4-E040-BB89AD432482","latestVersionIndicator":"Yes","beginDate":"2010-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8223-03C7-E063-731AD00A2106","beginDate":"2010-09-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"JAK2 V617 Positive","valueDescription":"JAK2 V617 Positive","ValueMeaning":{"publicId":"3144418","version":"1","preferredName":"JAK2 V617 Positive","longName":"3144418","preferredDefinition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"JAK2 NP_004963.1:p.V617X","conceptCode":"C117283","definition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"917B00C1-34E2-B5C4-E040-BB89AD432482","latestVersionIndicator":"Yes","beginDate":"2010-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8224-03C7-E063-731AD00A2106","beginDate":"2010-09-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"JAK2 V617 Negative","valueDescription":"JAK2 V617 Negative","ValueMeaning":{"publicId":"3144419","version":"1","preferredName":"JAK2 V617 Negative","longName":"3144419","preferredDefinition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"JAK2 NP_004963.1:p.V617X","conceptCode":"C117283","definition":"A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid. A change to phenylalanine at this position is associated with polycythemia vera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"917B00C1-3505-B5C4-E040-BB89AD432482","latestVersionIndicator":"Yes","beginDate":"2010-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8225-03C7-E063-731AD00A2106","beginDate":"2010-09-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"WT1 Not Tested","valueDescription":"WT1 Not Tested","ValueMeaning":{"publicId":"3131741","version":"1","preferredName":"WT1 Not Tested","longName":"3131741","preferredDefinition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WT1 Gene","conceptCode":"C18262","definition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-1F91-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8226-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"WT1 Positive","valueDescription":"WT1 Positive","ValueMeaning":{"publicId":"3131742","version":"1","preferredName":"WT1 Positive","longName":"3131742","preferredDefinition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WT1 Gene","conceptCode":"C18262","definition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-1FB4-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8227-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"WT1 Negative","valueDescription":"WT1 Negative","ValueMeaning":{"publicId":"3131743","version":"1","preferredName":"WT1 Negative","longName":"3131743","preferredDefinition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WT1 Gene","conceptCode":"C18262","definition":"This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-1FD7-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8228-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CEBPA Not Tested","valueDescription":"CEBPA Not Tested","ValueMeaning":{"publicId":"3131744","version":"1","preferredName":"CEBPA Not Tested","longName":"3131744","preferredDefinition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEBPA Gene","conceptCode":"C39598","definition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-1FFA-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8229-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CEBPA Positive","valueDescription":"CEBPA Positive","ValueMeaning":{"publicId":"3131745","version":"1","preferredName":"CEBPA Positive","longName":"3131745","preferredDefinition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEBPA Gene","conceptCode":"C39598","definition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-201D-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822A-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CEBPA Negative","valueDescription":"CEBPA Negative","ValueMeaning":{"publicId":"3131746","version":"1","preferredName":"CEBPA Negative","longName":"3131746","preferredDefinition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEBPA Gene","conceptCode":"C39598","definition":"This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-2040-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822B-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KIT Not Tested","valueDescription":"KIT Not Tested","ValueMeaning":{"publicId":"3131747","version":"1","preferredName":"KIT Not Tested","longName":"3131747","preferredDefinition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene","conceptCode":"C18609","definition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-2063-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822C-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KIT Positive","valueDescription":"KIT Positive","ValueMeaning":{"publicId":"3131748","version":"1","preferredName":"KIT Positive","longName":"3131748","preferredDefinition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene","conceptCode":"C18609","definition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-2086-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822D-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KIT Negative","valueDescription":"KIT Negative","ValueMeaning":{"publicId":"3131749","version":"1","preferredName":"KIT Negative","longName":"3131749","preferredDefinition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene","conceptCode":"C18609","definition":"This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8417A4-20A9-8F7D-E040-BB89AD431C3C","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822E-03C7-E063-731AD00A2106","beginDate":"2010-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Clinical Diagnosis Not Tested","valueDescription":"NF1 Gene Clinical Finding Not Tested","ValueMeaning":{"publicId":"3645798","version":"1","preferredName":"NF1 Gene Clinical Finding Not Tested","longName":"3645798","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign or Symptom","conceptCode":"C100104","definition":"Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A53C-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-822F-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Not Tested","valueDescription":"NF1 Gene Not Tested","ValueMeaning":{"publicId":"3645799","version":"1","preferredName":"NF1 Gene Not Tested","longName":"3645799","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A568-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8230-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Negative","valueDescription":"NF1 Gene Negative Finding","ValueMeaning":{"publicId":"3645800","version":"1","preferredName":"NF1 Gene Negative Finding","longName":"3645800","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A58E-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8231-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"VHL mutation","valueDescription":"VHL Gene Mutation","ValueMeaning":{"publicId":"4535609","version":"1","preferredName":"VHL Gene Mutation","longName":"4535609","preferredDefinition":"A change in the nucleotide sequence of the VHL gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VHL Gene Mutation","conceptCode":"C118400","definition":"A change in the nucleotide sequence of the VHL gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-33B0-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8232-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"TSC1/2 mutation","valueDescription":"TSC1 Gene Mutation TSC2 Gene Mutation","ValueMeaning":{"publicId":"4535608","version":"1","preferredName":"TSC1 Gene Mutation TSC2 Gene Mutation","longName":"4535608","preferredDefinition":"A change in the nucleotide sequence of the TSC1 gene.: A change in the nucleotide sequence of the TSC2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TSC1 Gene Mutation","conceptCode":"C118398","definition":"A change in the nucleotide sequence of the TSC1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TSC2 Gene Mutation","conceptCode":"C118399","definition":"A change in the nucleotide sequence of the TSC2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-338B-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8233-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"TRAP stain","valueDescription":"Tartrate Resistant Acid Phosphatase Staining Method","ValueMeaning":{"publicId":"4535605","version":"1","preferredName":"Tartrate Resistant Acid Phosphatase Staining Method","longName":"4535605","preferredDefinition":"TRAP Staining; TRACP Staining; TRAP Stain\r\n\r\nA staining method used to demonstrate the presence of acid phosphatase and tartrate resistant acid phosphatase (TRAP) in osteoclasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tartrate Resistant Acid Phosphatase Staining Method","conceptCode":"C118401","definition":"A staining method used to demonstrate the presence of acid phosphatase and tartrate resistant acid phosphatase (TRAP) in osteoclasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-331F-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8234-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SS18-SSX Fusion - SS18-SSX2","valueDescription":"SS18/SSX2 Fusion Protein","ValueMeaning":{"publicId":"4411276","version":"1","preferredName":"SS18/SSX2 Fusion Protein","longName":"4411276","preferredDefinition":"A fusion protein (488, ~54 kDa) encoded by the SS18/SSX2 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX2, including the SSX transcription repression domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18/SSX2 Fusion Protein","conceptCode":"C99396","definition":"A fusion protein (488, ~54 kDa) encoded by the SS18/SSX2 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX2, including the SSX transcription repression domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6DBC-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8235-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SS18-SSX Fusion - SS18-SSX1","valueDescription":"SS18/SSX1 Fusion Protein","ValueMeaning":{"publicId":"4411277","version":"1","preferredName":"SS18/SSX1 Fusion Protein","longName":"4411277","preferredDefinition":"A fusion protein (488 aa, ~54 kDa) encoded by the SS18/SSX1 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX1, including the SSX transcription repression domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18/SSX1 Fusion Protein","conceptCode":"C99394","definition":"A fusion protein (488 aa, ~54 kDa) encoded by the SS18/SSX1 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX1, including the SSX transcription repression domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6DE1-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8236-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SS18-SSX Fusion","valueDescription":"SS18-SSX Fusion Protein Expression","ValueMeaning":{"publicId":"4411275","version":"1","preferredName":"SS18-SSX Fusion Protein Expression","longName":"4411275","preferredDefinition":"The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18-SSX Fusion Protein Expression","conceptCode":"C43306","definition":"The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D97-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8237-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RET/PTC Rearrangement","valueDescription":"RET/PTC Rearrangement","ValueMeaning":{"publicId":"3743366","version":"1","preferredName":"RET/PTC Rearrangement","longName":"3743366","preferredDefinition":"A gene rearrangement involving the RET proto-oncogene. RET gene rearrangements are associated with several different neoplastic conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RET/PTC Rearrangement","conceptCode":"C46005","definition":"A gene rearrangement involving the RET proto-oncogene. RET gene rearrangements are associated with several different neoplastic conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD277B9-2F3B-7164-E040-BB89AD4339A8","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8238-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RAS mutation","valueDescription":"RAS Family Oncogene Mutation","ValueMeaning":{"publicId":"4889172","version":"1","preferredName":"RAS Family Oncogene Mutation","longName":"4889172","preferredDefinition":"A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the human ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation.: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RAS Family Oncogene","conceptCode":"C17061","definition":"A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the human ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation","conceptCode":"C0026882","definition":"Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-9728-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8239-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PSA elevated","valueDescription":"Elevated Prostate-Specific Antigen","ValueMeaning":{"publicId":"4411274","version":"1","preferredName":"Elevated Prostate-Specific Antigen","longName":"4411274","preferredDefinition":"Raised or increased above normal levels or limits.: Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D5D-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823A-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Positive","valueDescription":"NF1 Gene Positive Finding","ValueMeaning":{"publicId":"3645801","version":"1","preferredName":"NF1 Gene Positive Finding","longName":"3645801","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A5B4-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823B-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"VHL Not Tested","valueDescription":"VHL Gene Not Tested","ValueMeaning":{"publicId":"3645802","version":"1","preferredName":"VHL Gene Not Tested","longName":"3645802","preferredDefinition":"This gene is involved in transcriptional repression and protein degradation.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VHL Gene","conceptCode":"C18261","definition":"This gene is involved in transcriptional repression and protein degradation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A5DA-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823C-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"VHL Negative","valueDescription":"VHL Gene Negative Finding","ValueMeaning":{"publicId":"3645803","version":"1","preferredName":"VHL Gene Negative Finding","longName":"3645803","preferredDefinition":"This gene is involved in transcriptional repression and protein degradation.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VHL Gene","conceptCode":"C18261","definition":"This gene is involved in transcriptional repression and protein degradation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A600-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823D-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"VHL Positive","valueDescription":"VHL Gene Positive Finding","ValueMeaning":{"publicId":"3645804","version":"1","preferredName":"VHL Gene Positive Finding","longName":"3645804","preferredDefinition":"This gene is involved in transcriptional repression and protein degradation.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VHL Gene","conceptCode":"C18261","definition":"This gene is involved in transcriptional repression and protein degradation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A626-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823E-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RET Not Tested","valueDescription":"RET Gene Not Tested","ValueMeaning":{"publicId":"3645805","version":"1","preferredName":"RET Gene Not Tested","longName":"3645805","preferredDefinition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RET Gene","conceptCode":"C18257","definition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A64C-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-823F-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RET Negative","valueDescription":"RET Gene Negative Finding","ValueMeaning":{"publicId":"3645806","version":"1","preferredName":"RET Gene Negative Finding","longName":"3645806","preferredDefinition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RET Gene","conceptCode":"C18257","definition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A672-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8240-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RET Positive","valueDescription":"RET Gene Positive Finding","ValueMeaning":{"publicId":"3645807","version":"1","preferredName":"RET Gene Positive Finding","longName":"3645807","preferredDefinition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RET Gene","conceptCode":"C18257","definition":"This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A698-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8241-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Clinical Diagnosis Positive","valueDescription":"NF1 Gene Clinical Finding Positive","ValueMeaning":{"publicId":"3645808","version":"1","preferredName":"NF1 Gene Clinical Finding Positive","longName":"3645808","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign or Symptom","conceptCode":"C100104","definition":"Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A6C6-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8242-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MAX Not Tested","valueDescription":"MAX Gene Not Tested","ValueMeaning":{"publicId":"3645818","version":"1","preferredName":"MAX Gene Not Tested","longName":"3645818","preferredDefinition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MAX Gene","conceptCode":"C18576","definition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A709-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8243-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"TMEM 127 Not Tested","valueDescription":"TMEM127 Gene Not Tested","ValueMeaning":{"publicId":"3645820","version":"1","preferredName":"TMEM127 Gene Not Tested","longName":"3645820","preferredDefinition":"This gene may play a role in signaling and protein trafficking.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TMEM127 Gene","conceptCode":"C95303","definition":"This gene may play a role in signaling and protein trafficking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A736-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8244-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHAF2 (SDH5) Not Tested","valueDescription":"SDHAF2 Gene Not Tested","ValueMeaning":{"publicId":"3645822","version":"1","preferredName":"SDHAF2 Gene Not Tested","longName":"3645822","preferredDefinition":"This gene is involved in the electron transport chain.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHAF2 Gene","conceptCode":"C97770","definition":"This gene is involved in the electron transport chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A763-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8245-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHD Not Tested","valueDescription":"SDHD Gene Not Tested","ValueMeaning":{"publicId":"3645824","version":"1","preferredName":"SDHD Gene Not Tested","longName":"3645824","preferredDefinition":"This gene plays a role in the localization of succinate dehydrogenase activity.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHD Gene","conceptCode":"C97779","definition":"This gene plays a role in the localization of succinate dehydrogenase activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A790-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8246-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHC Not Tested","valueDescription":"SDHC Gene Not Tested","ValueMeaning":{"publicId":"3645826","version":"1","preferredName":"SDHC Gene Not Tested","longName":"3645826","preferredDefinition":"This gene is involved in mitochondrial electron transport.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHC Gene","conceptCode":"C97776","definition":"This gene is involved in mitochondrial electron transport.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A7BD-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8247-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHB Not Tested","valueDescription":"SDHB Gene Not Tested","ValueMeaning":{"publicId":"3645828","version":"1","preferredName":"SDHB Gene Not Tested","longName":"3645828","preferredDefinition":"This gene plays a role in electron transport in the mitochondria.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHB Gene","conceptCode":"C97773","definition":"This gene plays a role in electron transport in the mitochondria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A7EA-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8248-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MAX Negative","valueDescription":"MAX Gene Negative Finding","ValueMeaning":{"publicId":"3645829","version":"1","preferredName":"MAX Gene Negative Finding","longName":"3645829","preferredDefinition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MAX Gene","conceptCode":"C18576","definition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A821-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8249-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MAX Positive","valueDescription":"MAX Gene Positive Finding","ValueMeaning":{"publicId":"3645830","version":"1","preferredName":"MAX Gene Positive Finding","longName":"3645830","preferredDefinition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MAX Gene","conceptCode":"C18576","definition":"This gene is involved in transcriptional regulation and plays a role in the mediation of DNA-protein interactions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110377B-A847-7855-E040-BB89AD434401","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824A-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHAF2 (SDH5) Negative","valueDescription":"SDHAF2 Gene Negative Finding","ValueMeaning":{"publicId":"3645831","version":"1","preferredName":"SDHAF2 Gene Negative Finding","longName":"3645831","preferredDefinition":"This gene is involved in the electron transport chain.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHAF2 Gene","conceptCode":"C97770","definition":"This gene is involved in the electron transport chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11146FB-1B65-BF9D-E040-BB89AD434378","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824B-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHAF2 (SDH5) Positive","valueDescription":"SDHAF2 Gene Positive Finding","ValueMeaning":{"publicId":"3645832","version":"1","preferredName":"SDHAF2 Gene Positive Finding","longName":"3645832","preferredDefinition":"This gene is involved in the electron transport chain.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHAF2 Gene","conceptCode":"C97770","definition":"This gene is involved in the electron transport chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11146FB-1B8B-BF9D-E040-BB89AD434378","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824C-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHB Negative","valueDescription":"SDHB Gene Negative Finding","ValueMeaning":{"publicId":"3645833","version":"1","preferredName":"SDHB Gene Negative Finding","longName":"3645833","preferredDefinition":"This gene plays a role in electron transport in the mitochondria.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHB Gene","conceptCode":"C97773","definition":"This gene plays a role in electron transport in the mitochondria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11146FB-1BB2-BF9D-E040-BB89AD434378","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824D-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHB Positive","valueDescription":"SDHB Gene Positive Finding","ValueMeaning":{"publicId":"3645834","version":"1","preferredName":"SDHB Gene Positive Finding","longName":"3645834","preferredDefinition":"This gene plays a role in electron transport in the mitochondria.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHB Gene","conceptCode":"C97773","definition":"This gene plays a role in electron transport in the mitochondria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11146FB-1BD8-BF9D-E040-BB89AD434378","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824E-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 Clinical Diagnosis Negative","valueDescription":"NF1 Gene Clinical Finding Negative","ValueMeaning":{"publicId":"3645814","version":"1","preferredName":"NF1 Gene Clinical Finding Negative","longName":"3645814","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.: Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign or Symptom","conceptCode":"C100104","definition":"Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2E66-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-824F-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHA Not Tested","valueDescription":"SDHA Gene Not Tested","ValueMeaning":{"publicId":"3645873","version":"1","preferredName":"SDHA Gene Not Tested","longName":"3645873","preferredDefinition":"This gene is involved in the mitochondrial respiratory chain.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHA Gene","conceptCode":"C103873","definition":"This gene is involved in the mitochondrial respiratory chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1139AD0-C957-2F5A-E040-BB89AD435866","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8250-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHA Negative","valueDescription":"SDHA Gene Negative Finding","ValueMeaning":{"publicId":"3645874","version":"1","preferredName":"SDHA Gene Negative Finding","longName":"3645874","preferredDefinition":"This gene is involved in the mitochondrial respiratory chain.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHA Gene","conceptCode":"C103873","definition":"This gene is involved in the mitochondrial respiratory chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1139AD0-C97A-2F5A-E040-BB89AD435866","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8251-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHA Positive","valueDescription":"SDHA Gene Positive Finding","ValueMeaning":{"publicId":"3645875","version":"1","preferredName":"SDHA Gene Positive Finding","longName":"3645875","preferredDefinition":"This gene is involved in the mitochondrial respiratory chain.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHA Gene","conceptCode":"C103873","definition":"This gene is involved in the mitochondrial respiratory chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1139AD0-C99D-2F5A-E040-BB89AD435866","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8252-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHC Negative","valueDescription":"SDHC Gene Negative Finding","ValueMeaning":{"publicId":"3645835","version":"1","preferredName":"SDHC Gene Negative Finding","longName":"3645835","preferredDefinition":"This gene is involved in mitochondrial electron transport.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHC Gene","conceptCode":"C97776","definition":"This gene is involved in mitochondrial electron transport.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7AC9-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8253-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHC Positive","valueDescription":"SDHC Gene Positive Finding","ValueMeaning":{"publicId":"3645836","version":"1","preferredName":"SDHC Gene Positive Finding","longName":"3645836","preferredDefinition":"This gene is involved in mitochondrial electron transport.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHC Gene","conceptCode":"C97776","definition":"This gene is involved in mitochondrial electron transport.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7AEF-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8254-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHD Negative","valueDescription":"SDHD Gene Negative Finding","ValueMeaning":{"publicId":"3645837","version":"1","preferredName":"SDHD Gene Negative Finding","longName":"3645837","preferredDefinition":"This gene plays a role in the localization of succinate dehydrogenase activity.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHD Gene","conceptCode":"C97779","definition":"This gene plays a role in the localization of succinate dehydrogenase activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7B16-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8255-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"SDHD Positive","valueDescription":"SDHD Gene Positive Finding","ValueMeaning":{"publicId":"3645838","version":"1","preferredName":"SDHD Gene Positive Finding","longName":"3645838","preferredDefinition":"This gene plays a role in the localization of succinate dehydrogenase activity.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SDHD Gene","conceptCode":"C97779","definition":"This gene plays a role in the localization of succinate dehydrogenase activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7B3C-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8256-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"TMEM 127 Negative","valueDescription":"TMEM127 Gene Negative Finding","ValueMeaning":{"publicId":"3645841","version":"1","preferredName":"TMEM127 Gene Negative Finding","longName":"3645841","preferredDefinition":"This gene may play a role in signaling and protein trafficking.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TMEM127 Gene","conceptCode":"C95303","definition":"This gene may play a role in signaling and protein trafficking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7BAC-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8257-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"TMEM 127 Positive","valueDescription":"TMEM127 Gene Positive Finding","ValueMeaning":{"publicId":"3645842","version":"1","preferredName":"TMEM127 Gene Positive Finding","longName":"3645842","preferredDefinition":"This gene may play a role in signaling and protein trafficking.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TMEM127 Gene","conceptCode":"C95303","definition":"This gene may play a role in signaling and protein trafficking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D11153AB-7BD2-0FEC-E040-BB89AD430C3D","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8258-03C7-E063-731AD00A2106","beginDate":"2012-12-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"DNA Mismatch Repair Not Tested","valueDescription":"Mismatch Repair Not Tested","ValueMeaning":{"publicId":"4459564","version":"1","preferredName":"Mismatch Repair Not Tested","longName":"4459564","preferredDefinition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair","conceptCode":"C20639","definition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-44F7-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8259-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"DNA Mismatch Repair Negative","valueDescription":"Mismatch Repair Negative Finding","ValueMeaning":{"publicId":"4459565","version":"1","preferredName":"Mismatch Repair Negative Finding","longName":"4459565","preferredDefinition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair","conceptCode":"C20639","definition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-451D-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825A-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"DNA Mismatch Repair Positive","valueDescription":"Mismatch Repair Positive Finding","ValueMeaning":{"publicId":"4459566","version":"1","preferredName":"Mismatch Repair Positive Finding","longName":"4459566","preferredDefinition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair","conceptCode":"C20639","definition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4543-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825B-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FAP Not Tested","valueDescription":"FAP Gene Not Tested","ValueMeaning":{"publicId":"4459567","version":"1","preferredName":"FAP Gene Not Tested","longName":"4459567","preferredDefinition":"This gene is involved in the regulation of fibroblast growth.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FAP Gene","conceptCode":"C26582","definition":"This gene is involved in the regulation of fibroblast growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4569-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825C-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FAP Negative","valueDescription":"FAP Gene Negative Finding","ValueMeaning":{"publicId":"4459568","version":"1","preferredName":"FAP Gene Negative Finding","longName":"4459568","preferredDefinition":"This gene is involved in the regulation of fibroblast growth.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FAP Gene","conceptCode":"C26582","definition":"This gene is involved in the regulation of fibroblast growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-458F-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825D-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FAP Positive","valueDescription":"FAP Gene Positive Finding","ValueMeaning":{"publicId":"4459569","version":"1","preferredName":"FAP Gene Positive Finding","longName":"4459569","preferredDefinition":"This gene is involved in the regulation of fibroblast growth.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FAP Gene","conceptCode":"C26582","definition":"This gene is involved in the regulation of fibroblast growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-45B5-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825E-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NFI Positive","valueDescription":"NFIC Gene Positive Finding","ValueMeaning":{"publicId":"4459761","version":"1","preferredName":"NFIC Gene Positive Finding","longName":"4459761","preferredDefinition":"This gene is involved in transcriptional regulation.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFIC Gene","conceptCode":"C38403","definition":"This gene is involved in transcriptional regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4764-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-825F-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NFI Negative","valueDescription":"NFIC Gene Negative Finding","ValueMeaning":{"publicId":"4459571","version":"1","preferredName":"NFIC Gene Negative Finding","longName":"4459571","preferredDefinition":"This gene is involved in transcriptional regulation.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFIC Gene","conceptCode":"C38403","definition":"This gene is involved in transcriptional regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-45F1-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8260-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MEN1 Not Tested","valueDescription":"MEN1 Gene Not Tested","ValueMeaning":{"publicId":"4459572","version":"1","preferredName":"MEN1 Gene Not Tested","longName":"4459572","preferredDefinition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MEN1 Gene","conceptCode":"C18254","definition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-461A-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8261-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MEN1 Negative","valueDescription":"MEN1 Gene Negative Finding","ValueMeaning":{"publicId":"4459573","version":"1","preferredName":"MEN1 Gene Negative Finding","longName":"4459573","preferredDefinition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MEN1 Gene","conceptCode":"C18254","definition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4640-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8262-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MEN1 Positive","valueDescription":"MEN1 Gene Positive Finding","ValueMeaning":{"publicId":"4459574","version":"1","preferredName":"MEN1 Gene Positive Finding","longName":"4459574","preferredDefinition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MEN1 Gene","conceptCode":"C18254","definition":"This gene is involved in transcriptional regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-4666-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8263-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"P53 Not Tested","valueDescription":"TP53 Gene Not Tested","ValueMeaning":{"publicId":"4459625","version":"1","preferredName":"TP53 Gene Not Tested","longName":"4459625","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-468C-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8264-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"P53 Negative","valueDescription":"TP53 Gene Negative Finding","ValueMeaning":{"publicId":"4459743","version":"1","preferredName":"TP53 Gene Negative Finding","longName":"4459743","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-46B2-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8265-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"P53 Positive","valueDescription":"TP53 Gene Positive Finding","ValueMeaning":{"publicId":"4459744","version":"1","preferredName":"TP53 Gene Positive Finding","longName":"4459744","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-46D8-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8266-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NFI Not Tested","valueDescription":"NFIC Gene Not Tested","ValueMeaning":{"publicId":"4459745","version":"1","preferredName":"NFIC Gene Not Tested","longName":"4459745","preferredDefinition":"This gene is involved in transcriptional regulation.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFIC Gene","conceptCode":"C38403","definition":"This gene is involved in transcriptional regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0129DD46-472E-AA2A-E050-BB89AD431628","latestVersionIndicator":"Yes","beginDate":"2014-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8267-03C7-E063-731AD00A2106","beginDate":"2014-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R172 Positive","valueDescription":"IDH2 R172 Positive","ValueMeaning":{"publicId":"4474241","version":"1","preferredName":"IDH2 R172 Positive","longName":"4474241","preferredDefinition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R172X","conceptCode":"C117282","definition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B490-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8268-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R172 Not Tested","valueDescription":"IDH2 R172 Not Tested","ValueMeaning":{"publicId":"4474242","version":"1","preferredName":"IDH2 R172 Not Tested","longName":"4474242","preferredDefinition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R172X","conceptCode":"C117282","definition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B4B6-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8269-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Her2 amplification","valueDescription":"ERBB2 Gene Amplification","ValueMeaning":{"publicId":"4521432","version":"1","preferredName":"ERBB2 Gene Amplification","longName":"4521432","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the ERBB2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene Amplification","conceptCode":"C36638","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the ERBB2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-85E6-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826A-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - p53 mutation","valueDescription":"Germline Genotype Testing TP53 Gene Mutation","ValueMeaning":{"publicId":"4535021","version":"1","preferredName":"Germline Genotype Testing TP53 Gene Mutation","longName":"4535021","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-982F-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826B-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - Other","valueDescription":"Germline Genotype Testing Other","ValueMeaning":{"publicId":"4535020","version":"1","preferredName":"Germline Genotype Testing Other","longName":"4535020","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9809-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826C-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - NF1 mutation","valueDescription":"Germline Genotype Testing NF1 Gene Mutation","ValueMeaning":{"publicId":"4535019","version":"1","preferredName":"Germline Genotype Testing NF1 Gene Mutation","longName":"4535019","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the NF1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NF1 Gene Mutation","conceptCode":"C118388","definition":"A change in the nucleotide sequence of the NF1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-97E3-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826D-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Germline Genotype Testing - MEN1 mutation","valueDescription":"Germline Genotype Testing MEN1 Gene Mutation","ValueMeaning":{"publicId":"4535018","version":"1","preferredName":"Germline Genotype Testing MEN1 Gene Mutation","longName":"4535018","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the MEN1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MEN1 Gene Mutation","conceptCode":"C118387","definition":"A change in the nucleotide sequence of the MEN1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-97BD-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826E-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PMS2 mutation","valueDescription":"PMS2 Gene Mutation","ValueMeaning":{"publicId":"4535604","version":"1","preferredName":"PMS2 Gene Mutation","longName":"4535604","preferredDefinition":"A change in the nucleotide sequence of the PMS2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PMS2 Gene Mutation","conceptCode":"C118397","definition":"A change in the nucleotide sequence of the PMS2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32FA-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-826F-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PIK3CA mutation","valueDescription":"PIK3CA Mutation","ValueMeaning":{"publicId":"4411273","version":"1","preferredName":"PIK3CA Mutation","longName":"4411273","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the PI3KCA (phosphatidyl inositol 3-kinase) gene on chromosome 3q26.32.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3CA Gene Mutation","conceptCode":"C96271","definition":"A change in the nucleotide sequence of the PIK3CA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D3A-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8270-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R172 Negative","valueDescription":"IDH2 R172 Negative","ValueMeaning":{"publicId":"4474243","version":"1","preferredName":"IDH2 R172 Negative","longName":"4474243","preferredDefinition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R172X","conceptCode":"C117282","definition":"A change in the amino acid residue at position 172 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B4DC-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8271-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R140 Positive","valueDescription":"IDH2 R140 Positive","ValueMeaning":{"publicId":"4474244","version":"1","preferredName":"IDH2 R140 Positive","longName":"4474244","preferredDefinition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R140X","conceptCode":"C117281","definition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B502-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8272-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R140 Not Tested","valueDescription":"IDH2 R140 Not Tested","ValueMeaning":{"publicId":"4474245","version":"1","preferredName":"IDH2 R140 Not Tested","longName":"4474245","preferredDefinition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R140X","conceptCode":"C117281","definition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B528-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8273-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 R140 Negative","valueDescription":"IDH2 R140 Negative ","ValueMeaning":{"publicId":"4474246","version":"1","preferredName":"IDH2 R140 Negative ","longName":"4474246","preferredDefinition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 NP_002159.2:p.R140X","conceptCode":"C117281","definition":"A change in the amino acid residue at position 140 in the isocitrate dehydrogenase [NADP], mitochondrial protein where arginine has been replaced by another amino acid. Mutations at this position are found in patients with acute myeloid leukemia following myelodysplastic syndromes and is associated with shorter overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"022E9988-B54E-360E-E050-BB89AD43202C","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8274-03C7-E063-731AD00A2106","beginDate":"2014-09-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR activating mutation","valueDescription":"EGFR Activating Mutation","ValueMeaning":{"publicId":"4514722","version":"1","preferredName":"EGFR Activating Mutation","longName":"4514722","preferredDefinition":"A somatic mutation of the epidermal growth factor receptor gene which encodes a 170kDa transmembrane protein, a short transmembrane region, and an intracellular domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating EGFR Gene Mutation","conceptCode":"C92172","definition":"A somatic mutation of the epidermal growth factor receptor gene which encodes a constitutively active 170kDa transmembrane protein, a short transmembrane region, and an intracellular domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A66-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8275-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EBV Positive","valueDescription":"Epstein-Barr Virus Positive","ValueMeaning":{"publicId":"4621616","version":"1","preferredName":"Epstein-Barr Virus Positive","longName":"4621616","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4E69-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8276-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EBV","valueDescription":"Epstein-Barr Virus","ValueMeaning":{"publicId":"2567477","version":"1","preferredName":"Epstein-Barr Virus","longName":"2567477","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4A2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8277-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Co-amplification of HER2 and Chromosome 17","valueDescription":"EGFR Gene Amplification Gain of Chromosome 17","ValueMeaning":{"publicId":"4535011","version":"1","preferredName":"EGFR Gene Amplification Gain of Chromosome 17","longName":"4535011","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.: A cytogenetic abnormality that refers to the allelic gain of all or part of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene Amplification","conceptCode":"C36649","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gain of Chromosome 17","conceptCode":"C36466","definition":"A cytogenetic abnormality that refers to the allelic gain of all or part of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-96BC-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8278-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"cKIT mutation","valueDescription":"KIT Gene Mutation","ValueMeaning":{"publicId":"4514717","version":"1","preferredName":"KIT Gene Mutation","longName":"4514717","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A18-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8279-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD79B","valueDescription":"CD79B Gene","ValueMeaning":{"publicId":"4408821","version":"1","preferredName":"CD79B Gene","longName":"4408821","preferredDefinition":"This gene plays a role in signaling in B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD79B Gene","conceptCode":"C97424","definition":"This gene plays a role in signaling in B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2DD8-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827A-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD5","valueDescription":"CD5 Gene","ValueMeaning":{"publicId":"3991506","version":"1","preferredName":"CD5 Gene","longName":"3991506","preferredDefinition":"This gene may be involved in the proliferation of T-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD5 Gene","conceptCode":"C73121","definition":"This gene may be involved in the proliferation of T-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED596A54-CE09-6922-E040-BB89AD437737","latestVersionIndicator":"Yes","beginDate":"2013-12-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827B-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD45","valueDescription":"Receptor-Type Tyrosine-Protein Phosphatase C","ValueMeaning":{"publicId":"4514716","version":"1","preferredName":"Receptor-Type Tyrosine-Protein Phosphatase C","longName":"4514716","preferredDefinition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Receptor-Type Tyrosine-Protein Phosphatase C","conceptCode":"C17282","definition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-79F5-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827C-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD23","valueDescription":"Low Affinity Immunoglobulin Epsilon Fc Receptor","ValueMeaning":{"publicId":"3241852","version":"1","preferredName":"Low Affinity Immunoglobulin Epsilon Fc Receptor","longName":"3241852","preferredDefinition":": Low affinity immunoglobulin epsilon Fc receptor (321 aa, ~36 kDa) is encoded by the human FCER2 gene. This protein is involved in B cell differentiation and IgE production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Affinity Immunoglobulin Epsilon Fc Receptor","conceptCode":"C96902","definition":"Low affinity immunoglobulin epsilon Fc receptor (321 aa, ~36 kDa) is encoded by the human FCER2 gene. This protein is involved in B cell differentiation and IgE production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4977EB6-0693-43B2-E040-BB89AD435E91","latestVersionIndicator":"Yes","beginDate":"2011-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-31","modifiedBy":"ONEDATA","dateModified":"2011-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827D-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD22","valueDescription":"CD22 Gene","ValueMeaning":{"publicId":"3649406","version":"1","preferredName":"CD22 Gene","longName":"3649406","preferredDefinition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD22 Gene","conceptCode":"C20990","definition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B64039-CBBB-975D-E040-BB89AD437C62","latestVersionIndicator":"Yes","beginDate":"2013-01-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827E-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD20","valueDescription":"B-Lymphocyte Antigen CD20","ValueMeaning":{"publicId":"3991503","version":"1","preferredName":"B-Lymphocyte Antigen CD20","longName":"3991503","preferredDefinition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte Antigen CD20","conceptCode":"C38896","definition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED596A54-CDD6-6922-E040-BB89AD437737","latestVersionIndicator":"Yes","beginDate":"2013-12-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-827F-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CD19","valueDescription":"CD19 gene","ValueMeaning":{"publicId":"3261255","version":"1","preferredName":"CD19 gene","longName":"3261255","preferredDefinition":"This gene plays a role in signal transduction and regulates the response of B cells to antigens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD19 Gene","conceptCode":"C38886","definition":"This gene plays a role in signal transduction and regulates the response of B cells to antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6634-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-10","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8280-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BRCA2 Mutation","valueDescription":"BRCA2 Gene Mutation","ValueMeaning":{"publicId":"4408782","version":"1","preferredName":"BRCA2 Gene Mutation","longName":"4408782","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA2 Gene Mutation","conceptCode":"C19636","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ECAE-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8281-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BRCA1 Mutation","valueDescription":"BRCA1 Gene Mutation","ValueMeaning":{"publicId":"4408785","version":"1","preferredName":"BRCA1 Gene Mutation","longName":"4408785","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA1 Gene Mutation","conceptCode":"C19635","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ECF7-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8282-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BRAF mutation","valueDescription":"Mutation Abnormality BRAF Gene","ValueMeaning":{"publicId":"4408822","version":"1","preferredName":"Mutation Abnormality BRAF Gene","longName":"4408822","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"BRAF Gene","conceptCode":"C18363","definition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2DFE-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8283-03C7-E063-731AD00A2106","beginDate":"2015-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"p53 mutation","valueDescription":"TP53 Gene Mutation","ValueMeaning":{"publicId":"4535603","version":"1","preferredName":"TP53 Gene Mutation","longName":"4535603","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32D5-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8284-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF2 mutation","valueDescription":"NF2 Gene Mutation","ValueMeaning":{"publicId":"4514756","version":"1","preferredName":"NF2 Gene Mutation","longName":"4514756v1.00","preferredDefinition":"A molecular genetic abnormality that refers to the mutation of the NF2 gene located at 22q12.2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF2 Gene Mutation","conceptCode":"C45669","definition":"A molecular genetic abnormality that refers to the mutation of the NF2 gene located at 22q12.2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D88-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8285-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NF1 mutation","valueDescription":"NF1 Gene Mutation","ValueMeaning":{"publicId":"4535602","version":"1","preferredName":"NF1 Gene Mutation","longName":"4535602","preferredDefinition":"A change in the nucleotide sequence of the NF1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene Mutation","conceptCode":"C118388","definition":"A change in the nucleotide sequence of the NF1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32B0-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8286-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MSI high","valueDescription":"Elevated Microsatellite Instability","ValueMeaning":{"publicId":"4621615","version":"1","preferredName":"Elevated Microsatellite Instability","longName":"4621615","preferredDefinition":"Raised or increased above normal levels or limits.: Genomic instability associated with defective DNA mismatch repair in tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Microsatellite Instability","conceptCode":"C36318","definition":"Genomic instability associated with the presence of hypermutability in specific genetic marker regions resulting from defective DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4E43-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8287-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MSH6 mutation","valueDescription":"MSH6 Gene Mutation","ValueMeaning":{"publicId":"4535582","version":"1","preferredName":"MSH6 Gene Mutation","longName":"4535582","preferredDefinition":"A change in the nucleotide sequence of the MSH6 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MSH6 Gene Mutation","conceptCode":"C118395","definition":"A change in the nucleotide sequence of the MSH6 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C990-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8288-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MSH2 - expressed by PCR","valueDescription":"Gene Expression Polymerase Chain Reaction DNA Mismatch Repair Protein Msh2","ValueMeaning":{"publicId":"4521438","version":"1","preferredName":"Gene Expression Polymerase Chain Reaction DNA Mismatch Repair Protein Msh2","longName":"4521438","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: method for reproducing specific DNA sequences based on elongation of complementary primers by DNA polymerase; primarily used to increase quantities for analytical detection of, e.g., virus genome.: DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA Mismatch Repair Protein Msh2","conceptCode":"C21466","definition":"DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8710-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8289-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MSH2 - expressed by IHC","valueDescription":"Protein Expression Analysis Immunohistochemistry Staining Method DNA Mismatch Repair Protein Msh2","ValueMeaning":{"publicId":"4535601","version":"1","preferredName":"Protein Expression Analysis Immunohistochemistry Staining Method DNA Mismatch Repair Protein Msh2","longName":"4535601","preferredDefinition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.: Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.: DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression Analysis","conceptCode":"C63480","definition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA Mismatch Repair Protein Msh2","conceptCode":"C21466","definition":"DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-328B-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828A-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MLH1 mutation","valueDescription":"MLH1 Gene Mutation","ValueMeaning":{"publicId":"4535581","version":"1","preferredName":"MLH1 Gene Mutation","longName":"4535581","preferredDefinition":"A change in the nucleotide sequence of the MLH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MLH1 Gene Mutation","conceptCode":"C118394","definition":"A change in the nucleotide sequence of the MLH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C96B-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828B-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MLH1 expressed by PCR","valueDescription":"Gene Expression Polymerase Chain Reaction MLH1 Gene","ValueMeaning":{"publicId":"4521439","version":"1","preferredName":"Gene Expression Polymerase Chain Reaction MLH1 Gene","longName":"4521439","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: method for reproducing specific DNA sequences based on elongation of complementary primers by DNA polymerase; primarily used to increase quantities for analytical detection of, e.g., virus genome.: This gene plays a role in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MLH1 Gene","conceptCode":"C18482","definition":"This gene plays a role in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8737-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828C-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"MLH1 expressed by IHC","valueDescription":"Protein Expression Analysis Immunohistochemistry Staining Method MLH1 Gene","ValueMeaning":{"publicId":"4514751","version":"1","preferredName":"Protein Expression Analysis Immunohistochemistry Staining Method MLH1 Gene","longName":"4514751v1.00","preferredDefinition":"Any method of protein detection that can be used to quantify the level of a protein in a sample._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._This gene plays a role in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression Analysis","conceptCode":"C63480","definition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MLH1 Gene","conceptCode":"C18482","definition":"This gene plays a role in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D33-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828D-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS Other - amplification","valueDescription":"KRAS Other - amplification","ValueMeaning":{"publicId":"4514748","version":"1","preferredName":"KRAS Other - amplification","longName":"4514748v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._A molecular genetic abnormality indicating the presence of multiple copies of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Gene Amplification","conceptCode":"C36665","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D08-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828E-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation (NOS)","valueDescription":"KRAS Activating Mutation Not Otherwise Specified","ValueMeaning":{"publicId":"4535026","version":"1","preferredName":"KRAS Activating Mutation Not Otherwise Specified","longName":"4535026","preferredDefinition":"Not characterized in any other way.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-98E7-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-828F-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation - Codon Other","valueDescription":"KRAS mutation - Codon Other","ValueMeaning":{"publicId":"4521436","version":"1","preferredName":"KRAS mutation - Codon Other","longName":"4521436v1.00","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid._Different than the one(s) previously specified or mentioned._A change in the nucleotide sequence of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Gene Mutation","conceptCode":"C41361","definition":"A change in the nucleotide sequence of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8697-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8290-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 61","valueDescription":"KRAS mutation - Codon 61","ValueMeaning":{"publicId":"4535569","version":"1","preferredName":"KRAS mutation - Codon 61","longName":"4535569","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A number with no fractional part, including the negative and positive numbers as well as zero.::61: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C8FE-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8291-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 13","valueDescription":"KRAS mutation - Codon 13","ValueMeaning":{"publicId":"4535551","version":"1","preferredName":"KRAS mutation - Codon 13","longName":"4535551","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A natural number greater than 12 and less than 14 and the quantity that it denotes.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Thirteen","conceptCode":"C113427","definition":"A natural number greater than 12 and less than 14 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C8B9-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8292-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 12","valueDescription":"KRAS mutation - Codon 12","ValueMeaning":{"publicId":"4535051","version":"1","preferredName":"KRAS mutation - Codon 12","longName":"4535051","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twelve","conceptCode":"C113426","definition":"A natural number greater than 11 and less than 13 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-992B-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8293-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS mutation","valueDescription":"KRAS Activating Mutation","ValueMeaning":{"publicId":"4535025","version":"1","preferredName":"KRAS Activating Mutation","longName":"4535025","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-98C1-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8294-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G13D mutation","valueDescription":"KRAS NP_004976.2:p.G13D","ValueMeaning":{"publicId":"3528648","version":"1","preferredName":"KRAS NP_004976.2:p.G13D","longName":"3528648","preferredDefinition":"A change in the amino acid residue at position 13 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G13D","conceptCode":"C98403","definition":"A change in the amino acid residue at position 13 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F546-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2019-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8295-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12V mutation","valueDescription":"KRAS NP_004976.2:p.G12V","ValueMeaning":{"publicId":"3528656","version":"1","preferredName":"KRAS NP_004976.2:p.G12V","longName":"3528656","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by valine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12V","conceptCode":"C98391","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by valine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F5DE-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2018-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8296-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12S mutation","valueDescription":"KRAS NP_004976.2:p.G12S","ValueMeaning":{"publicId":"3528654","version":"1","preferredName":"KRAS NP_004976.2:p.G12S","longName":"3528654","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12S","conceptCode":"C98389","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F5B8-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8297-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12R mutation","valueDescription":"KRAS NP_004976.2:p.G12R","ValueMeaning":{"publicId":"3528652","version":"1","preferredName":"KRAS NP_004976.2:p.G12R","longName":"3528652","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12R","conceptCode":"C98386","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F592-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8298-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12D mutation","valueDescription":"KRAS NP_004976.2:p.G12D","ValueMeaning":{"publicId":"3528660","version":"1","preferredName":"KRAS NP_004976.2:p.G12D","longName":"3528660","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12D","conceptCode":"C98369","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F62A-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-8299-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12C mutation","valueDescription":"KRAS NP_004976.2:p.G12C","ValueMeaning":{"publicId":"3528650","version":"1","preferredName":"KRAS NP_004976.2:p.G12C","longName":"3528650","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by cysteine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12C","conceptCode":"C98365","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by cysteine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F56C-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829A-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS G12A mutation","valueDescription":"KRAS NP_004976.2:p.G12A","ValueMeaning":{"publicId":"3528658","version":"1","preferredName":"KRAS NP_004976.2:p.G12A","longName":"3528658","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by alanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12A","conceptCode":"C98363","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by alanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F604-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829B-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS - activating mutations","valueDescription":"KRAS Activating Mutation","ValueMeaning":{"publicId":"4535025","version":"1","preferredName":"KRAS Activating Mutation","longName":"4535025","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-98C1-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829C-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"isochrome 17","valueDescription":"i(17q)","ValueMeaning":{"publicId":"4422301","version":"1","preferredName":"i(17q)","longName":"4422301","preferredDefinition":"A cytogenetic abnormality involving chromosome 17 that results from loss of the short arm and duplication of the long arm. This aberration is associated with a variety of neoplastic diseases, and is indicative of a poor prognosis for individuals with hematologic malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"i(17q)","conceptCode":"C36477","definition":"A cytogenetic abnormality involving chromosome 17 that results from loss of the short arm and duplication of the long arm. This aberration is associated with a variety of neoplastic diseases, and is indicative of a poor prognosis for individuals with hematologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FFCEFDAA-3E11-D5E0-E040-BB89AD432BA1","latestVersionIndicator":"Yes","beginDate":"2014-08-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829D-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IgVH gene mutation","valueDescription":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","ValueMeaning":{"publicId":"4514744","version":"1","preferredName":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","longName":"4514744","preferredDefinition":"A change in the nucleotide sequence of the variable region of the immunoglobulin heavy chain locus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","conceptCode":"C111690","definition":"A change in the nucleotide sequence of the variable region of the immunoglobulin heavy chain locus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C9C-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829E-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH2 Mutation","valueDescription":"IDH2 Mutation","ValueMeaning":{"publicId":"4535023","version":"1","preferredName":"IDH2 Mutation","longName":"4535023","preferredDefinition":"A change in the nucleotide sequence of the IDH2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 Gene Mutation","conceptCode":"C118390","definition":"A change in the nucleotide sequence of the IDH2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9879-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-829F-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"IDH1 Mutation","valueDescription":"IDH1 Gene Mutation","ValueMeaning":{"publicId":"4535022","version":"1","preferredName":"IDH1 Gene Mutation","longName":"4535022","preferredDefinition":"A change in the nucleotide sequence of the IDH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 Gene Mutation","conceptCode":"C118389","definition":"A change in the nucleotide sequence of the IDH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9854-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A0-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"KRAS Other - mutations","valueDescription":"KRAS Activating Mutation Other","ValueMeaning":{"publicId":"4889091","version":"1","preferredName":"KRAS Activating Mutation Other","longName":"4889091","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BDE96C-F918-DC12-E050-BB89AD432B2A","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A1-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A2-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 1","valueDescription":"EML4/ALK Fusion Gene Variant 1","ValueMeaning":{"publicId":"4408818","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 1","longName":"4408818","preferredDefinition":"A fusion gene (~3.9 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 13 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 1","conceptCode":"C99725","definition":"A fusion gene (~3.9 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 13 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D4E-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A3-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"EGFR amplification","valueDescription":"EGFR Gene Amplification","ValueMeaning":{"publicId":"4535012","version":"1","preferredName":"EGFR Gene Amplification","longName":"4535012","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene Amplification","conceptCode":"C36649","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-96DF-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A4-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"PR - positive","valueDescription":"Progesterone Receptor Positive","ValueMeaning":{"publicId":"4411285","version":"1","preferredName":"Progesterone Receptor Positive","longName":"4411285","preferredDefinition":"Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor positive need progesterone to grow and will usually stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor Positive","conceptCode":"C15496","definition":"An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6E85-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A5-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"trisomy 10","valueDescription":"Trisomy 10","ValueMeaning":{"publicId":"4535606","version":"1","preferredName":"Trisomy 10","longName":"4535606","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 10","conceptCode":"C81729","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-3342-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A6-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"trisomy 5","valueDescription":"Trisomy 5","ValueMeaning":{"publicId":"4535607","version":"1","preferredName":"Trisomy 5","longName":"4535607","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 5 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 5","conceptCode":"C36433","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 5 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-3365-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A7-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"trisomy 8","valueDescription":"Trisomy 8","ValueMeaning":{"publicId":"2762293","version":"1","preferredName":"Trisomy 8","longName":"2762293","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 8","conceptCode":"C36396","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-013B-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A8-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"Zap70 expression","valueDescription":"Gene Expression ZAP70 Gene","ValueMeaning":{"publicId":"4411283","version":"1","preferredName":"Gene Expression ZAP70 Gene","longName":"4411283","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: This gene is involved in tyrosine phosphorylation and T-cell activation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ZAP70 Gene","conceptCode":"C26535","definition":"This gene is involved in tyrosine phosphorylation and T-cell activation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6E5F-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82A9-03C7-E063-731AD00A2106","beginDate":"2015-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"BCR-ABL1 Fusion Protein Expression","valueDescription":"BCR-ABL1 Fusion Protein Expression","ValueMeaning":{"publicId":"5497694","version":"1","preferredName":"BCR-ABL1 Fusion Protein Expression","longName":"5497694","preferredDefinition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia.  This rearrangement results in the formation of the BCR-ABL1 fusion protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR-ABL1 Fusion Protein Expression","conceptCode":"C36715","definition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia.  This rearrangement results in the formation of the BCR-ABL1 fusion protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DF9392D-F93D-2D20-E053-F662850A402F","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AA-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"RUNX1-RUNX11","valueDescription":"RUNX1-RUNX11","ValueMeaning":{"publicId":"7264725","version":"1","preferredName":"RUNX1-RUNX11","longName":"7264725v1.00","preferredDefinition":"A change in the nucleotide sequence of the RUNX1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RUNX1 Gene Mutation","conceptCode":"C38362","definition":"A change in the nucleotide sequence of the RUNX1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A45B99EA-EB4B-16DC-E053-F662850A5C88","latestVersionIndicator":"Yes","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2020-04-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AB-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"CBFB/MYH11 Fusion Gene","valueDescription":"CBFB/MYH11 Fusion Gene","ValueMeaning":{"publicId":"3704877","version":"1","preferredName":"CBFB/MYH11 Fusion Gene","longName":"3704877","preferredDefinition":"A fusion gene that results from a chromosomal inversion inv(16)(p13q22) which fuses the 5' portion of the CBFB gene with the 3' part of the MYH11 gene. This rearrangement is associated with acute myeloid leukemia and myelodysplastic syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CBFB/MYH11 Fusion Gene","conceptCode":"C101051","definition":"A fusion gene that results from a chromosomal inversion inv(16)(p13q22) which fuses the 5' portion of the CBFB gene with the 3' part of the MYH11 gene. This rearrangement is associated with acute myeloid leukemia and myelodysplastic syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D94E4760-A20E-AB66-E040-BB89AD437CAF","latestVersionIndicator":"Yes","beginDate":"2013-04-01","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-04-01","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AC-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"NPM1 Gene","valueDescription":"NPM1 Gene","ValueMeaning":{"publicId":"6142129","version":"1","preferredName":"NPM1 Gene","longName":"6142129","preferredDefinition":"This gene is involved in the regulation of ribosomal assembly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NPM1 Gene","conceptCode":"C21185","definition":"This gene is involved in the regulation of ribosomal assembly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67CCB734-ED39-4B40-E053-F662850A71CC","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-19","modifiedBy":"ONEDATA","dateModified":"2018-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AD-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FLT3-TKD","valueDescription":"FLT3-TKD","ValueMeaning":{"publicId":"7264726","version":"1","preferredName":"FLT3-TKD","longName":"7264726v1.00","preferredDefinition":"A mutation in the region of the FLT3 gene that encodes the second tyrosine kinase domain of the receptor-type tyrosine-protein kinase FLT3 that causes the stabilization of the activation loop of the kinase domain. FLT3 activation loop mutations lead to constitutive tyrosine kinase activity and are associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Activation Loop Mutation","conceptCode":"C120063","definition":"A mutation in the region of the FLT3 gene that encodes the second tyrosine kinase domain of the receptor-type tyrosine-protein kinase FLT3 that causes the stabilization of the activation loop of the kinase domain. FLT3 activation loop mutations lead to constitutive tyrosine kinase activity and are associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A45B99EA-EB97-16DC-E053-F662850A5C88","latestVersionIndicator":"Yes","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2020-04-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AE-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"},{"value":"FLT3-ITD","valueDescription":"FLT3 Internal Tandem Duplication","ValueMeaning":{"publicId":"3630974","version":"1","preferredName":"FLT3 Internal Tandem Duplication","longName":"3630974","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Internal Tandem Duplication","conceptCode":"C67494","definition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF94B6E0-9B06-7FAD-E040-BB89AD433160","latestVersionIndicator":"Yes","beginDate":"2012-11-28","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0903E928-82AF-03C7-E063-731AD00A2106","beginDate":"2020-04-28","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-31","modifiedBy":"ONEDATA","dateModified":"2023-10-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3121598","version":"1","preferredName":"Molecular Analysis Abnormality Testing Outcome","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).:A condition that differs from the usual physical or mental state.:A procedure for critical evaluation.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C19770:C9440:C15336:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5DD8D6-2A19-A834-E040-BB89AD432D73","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"ONEDATA","dateModified":"2010-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0903E931-0D92-03C3-E063-731AD00A67A2","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-31","modifiedBy":"KUMMEROA","dateModified":"2023-10-31","changeDescription":"6-29-2015: Versioned to add numerous PVs/TCGA/tt_Versioned to correct error with 6 PVs using IDH1 (R140 and R172)instead of IDH2.  Deleted incorrect PVs and added correct PVs with annotated VMs. mc 9/3/2014","administrativeNotes":"2023.9.24 Updated PV missing concepts. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"}]}],"AlternateNames":[{"name":"molecular_analysis_abnormality_testing_result","type":"TCGA_XML_Name","context":"NCIP"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"MOL_AN_ABN_RSLT","type":"OID, NCIP","context":"NCIP"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Molecular Abnormality Studies","url":null,"context":"NCIP"},{"name":"TCGA Alternate Question","type":"Alternate Question Text","description":"Type of Germline Genotype Testing Performed","url":null,"context":"NCIP"},{"name":"Princess Marg -1","type":"Alternate Question Text","description":"Molecular Results","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09041EEC-9FC9-0F76-E063-731AD00A0EFA","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-31","modifiedBy":"KUMMEROA","dateModified":"2023-10-31","changeDescription":"6/30/15: versioned due to VD changes & version/TCGA_tt. Versioned to correct error with 6 PVs using IDH1 (R140 and R172)instead of IDH2.  Deleted incorrect PVs and added correct PVs with annotated VMs. mc 9/3/2014","administrativeNotes":"2023.10.31 Versioned due to newer VD version needed. ak","unresolvedIssues":null,"deletedIndicator":"No"}}